How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
Baby formula fats may contribute to early liver disease
Share this Article You are free to share this article under the Attribution 4.0 International license. Certain fats…
New pathway found connecting liver congestion to fibrosis and cancer
Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through…
Hormone replacement therapy shows no rise in overall mortality
Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk…
Vascularized liver tissueoid-on-a-chip recreates tissue regeneration and transplant rejection
Dr. Vadim Jucaud’s lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates…
Could Lower Protein Intake Help Prevent Liver Cancer? New Research Points to a Possible Link
A recent study suggests reducing dietary protein may slow liver cancer development in people with impaired liver function,…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Expert guidance on fecal microbiota transplantation in liver disease
The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT),…
Gut bacteria compound during pregnancy protects offspring from fatty liver disease
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk…
Preclinical study reveals potential new treatment for severe liver fibrosis
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis – a dangerous, disease-induced build-up of…
Rush University Medical Center’s Dr. Steven Flamm talks alcohol use, liver disease, impact of drinking ahead of new year
CHICAGO (WLS) — As a new year approaches, many people are rethinking their habits, including how much alcohol…
Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier…